NASDAQ: EYES       Second Sight
Last Price Today's Change   Day's Range   Trading Volume
1.80   -0.14 (7.22%)  1.77 - 1.96  593,158


Avg Volume (4 weeks):0
52 Weeks Range:1.27 - 20.00
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Second Sight Medical Products Inc develops and manufactures implantable visual prosthetics that can restore some degree of functional vision to patients blinded by outer retinal degenerations. The firm’s key product is the Argus II system, which treats retinal degenerations, such as retinitis pigmentosa, a hereditary disease that causes the degeneration of light-sensitive retina cells and leads to vision impairment and blindness. Second Sight receives the largest proportion of revenue from sales in the United States. Sales in Europe contribute the second largest proportion of revenue.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2453  7781  858  603 

Top 10 Active Counters
 SQQQ 6.82+0.33 
 ARDX 1.52-0.18 
 SPY 453.42-3.98 
 VXX 27.96+2.24 
 DIDI 6.07-1.73 
 TQQQ 150.08-7.94 
 F 19.14-0.73 
 UVXY 23.50+2.70 
 AAPL 161.84-1.92 
 SNDL 0.564-0.028